FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
Tandem Diabetes (NASDAQ: TNDM) reported Q1 EPS of ($0.68), $0.01 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $20.1 million versus the consensus estimate of $17.67 million.
GUIDANCE:
Tandem Diabetes sees FY2016 revenue of $108-115 million, versus the consensus of... More

